The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial Fibrillation
February 19th 2015A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.
Read More